Acikgoz, Y., Y. Ergun, G. Ucar, M. Dirikoc, and D. Uncu. “The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-Positive Metastatic Breast Cancer Patients”. Acta Medica, vol. 50, no. 4, Dec. 2019, pp. 14-19, doi:10.32552/2019.ActaMedica.395.